BiotechTube
OakLabs

OakLabs

Berlin, Germany· Est.
oaklabs.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

OakLabs is a Berlin-based diagnostics company that combines advanced laboratory services with a proprietary AI engine to develop and analyze biomarkers for preventative health. Its core business involves providing custom R&D solutions to industry and research partners, while a newer direct-to-consumer arm, the Health Monitor, offers personalized health insights based on amino acid profiling. The company appears to be revenue-generating, supported by a service-based model and strategic laboratory partnerships, positioning it at the intersection of AI-driven diagnostics and personalized wellness.

Preventative HealthWellness

Technology Platform

Proprietary AI engine that integrates multiple biological molecules into composite biomarkers for high-precision analysis. Platform supports amino acid profiling and gene expression analysis via microarrays.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The growing global demand for AI-driven, preventative healthcare solutions creates a significant market for both its B2B biomarker services and its direct-to-consumer Health Monitor.
Expansion of the Health Monitor's biomarker panel and securing partnerships with larger wellness or healthcare providers could drive rapid scaling.

Risk Factors

Key risks include intense competition in both AI diagnostics and DTC health testing, potential regulatory hurdles for health claims, reliance on a key lab partner (MembraPure), and the challenge of achieving consumer adoption and trust in a crowded market without substantial marketing resources.

Competitive Landscape

OakLabs competes in the B2B space with other specialty CROs and bioinformatics firms, and in the DTC space with numerous at-home health testing companies (e.g., LetsGetChecked, Everlywell) and wellness platforms. Its differentiation lies in its proprietary AI integration of multiple molecules into a single biomarker and its dual B2B/B2C model.

More companies in Diagnostics & Precision Medicine →More companies in Germany →